A new tool to track infant development, starting at just 16 days old
August 25, 2025
Northwestern unveils NIH Baby Toolbox, the newest national standard to assess infants’ cognitive, emotional growth
Northwestern unveils NIH Baby Toolbox, the newest national standard to assess infants’ cognitive, emotional growth
OSTRAVA, Czech Republic, Aug. 19, 2025 /PRNewswire/ — Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) through its URIS® device to treat Parkinson’s disease symptoms.
West Nile virus (WNV) has been the dominant cause of mosquito-borne illness in the United States since its introduction into North America in 1999. There are no vaccines nor medications to prevent or treat illness in people, so surveillance, prevention, and control remain the best options to protect the public.
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 /PRNewswire/ — Calidar, Inc., an innovative start-up in precision diagnostic imaging, today announced the successful imaging of the first patient with its 4D Mammography system.
MicroPort NeuroScientific has launched its Numen coil embolization system in Egypt through a partnership with PentaMed.
A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published in JAMA Network Open.
Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.
Agile Medical Technology today took to social media to introduce its Agibot Endoscopic Surgical System, a surgical robotic platform for endoscopic procedures.
TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ — Today Dräger, an international leader in medical and safety technologies, announced that the company’s Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense’s (DoD) Risk Management Framework (RMF) eMASS #4060.
Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.